Advertisement
Advertisement

ANNX

ANNX logo

Annexon, Inc. Common Stock

6.23
USD
Sponsored
-0.29
-4.51%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

6.17

-0.05
-0.82%

ANNX Earnings Reports

Positive Surprise Ratio

ANNX beat 11 of 22 last estimates.

50%

Next Report

Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.32
Implied change from Q3 25 (Revenue/ EPS)
--
/
-13.51%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-3.03%

Annexon, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, ANNX reported earnings of -0.37 USD per share (EPS) for Q3 25, missing the estimate of -0.34 USD, resulting in a -6.69% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an decrease of -13.51% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Annexon, Inc. Common Stock reported EPS of -$0.37, missing estimates by -6.69%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.34%, changed from $2.98 before the earnings release to $2.97 the day after.
The next earning report is scheduled for Mar 02, 2026.
Based on 12 analysts, Annexon, Inc. Common Stock is expected to report EPS of -$0.32 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement